[1] Wesolowska-Andersen A,Everman J L,Davidson R,et al.Dual RNA-seq reveals viral infections in asthmatic children without respiratory illness which are associated with changes in the airway transcriptome[J].GENOME BIOLOGY,2017,18(1):1-17. [2] 杨明明,卢慧娜,周瑜,等.冬病夏治三伏贴联合吸入糖皮质激素治疗儿童哮喘的疗效分析[J].重庆医学,2020,49(03):387-390. [3] Butz A M,Bollinger M E,Ogborn J,et al.Children with poorly controlled asthma:Randomized controlled trial of a home based environmental control intervention[J].PEDIATR PULM,2019,54(3):245-256. [4] 中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童支气管哮喘诊断与防治指南(2016年版)[J].中华儿科杂志,2016,54(3):167-181. [5] Omole K O,Kuti B P,Oyelami O A,et al.Serum vitamin D profile of Nigerian children with asthma:Association with asthma severity and control[J].PEDIATR PULM,2018,53(5):544-551. [6] 朱晓弘,涂金伟,代继宏.丙酸氟替卡松、孟鲁斯特钠、酮替芬治疗儿童咳嗽变异性哮喘的临床疗效观察[J].中国当代儿科杂志,2019,21(4):393-398. [7] 辛庆锋,孙有利,康美清,等.沙美特罗替卡松治疗咳嗽变异性哮喘及延缓复发的效果研究[J].中国全科医学,2020,23(26):3280-3285. [8] 宋元玉,陈霞,应赟.哮喘患儿病情控制现状及影响哮喘控制的因素分析[J].中国妇幼保健,2019,34(12):2831-2833. [9] 韩曙光,赵弘卿,吕蕾,等.影响支气管哮喘控制水平的多因素Logistic分析[J].临床肺科杂志,2018,23(5):951-955. [10] Karrasch S,Linde K,Rücker G,et al.Accuracy of FENO for diagnosing asthma:a systematic review[J].THORAX,2017,72(2):109-116. [11] 王傲杰,刘长山.哮喘儿童吸入性糖皮质激素规范治疗停药后复发相关因素的分析[J].实用药物与临床,2018,21(5):536-540. [12] Li H,Chen Z,Lin Y,et al.CpG-ODNs and budesonide act synergistically to improve allergic responses in combined allergic rhinitis and asthma syndrome induced by chronic exposure to ovalbumin by modulating the TSLP-DC-OX40L axis[J].INFLAMMATION,2018,41(4):1304-1320. [13] 王金永. 哮喘儿童规范治疗停药后复发的高危因素分析[J].临床肺科杂志,2018,23(12):2296-2299. [14] 胡巍,杨凡,张桂凡,等.老年支气管哮喘病人慢性持续期控制情况的影响因素分析[J].药学服务与研究,2019,19(3):233-234,237. [15] 冷婷. 294例支气管哮喘患者控制现状及影响因素分析[J].实用医院临床杂志,2019,16(1):24-27.
2023, Vol. 43 
